Market Overview:
The global point of care and rapid diagnostic market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of infectious diseases, rising demand for homecare diagnostics, and growing adoption of digital diagnostics. The point-of-care (POC) and rapid diagnostic market is segmented on the basis of type into self-monitoring blood glucose (SMBG), infectious disease, coagulation, and other tests. The SMBG segment is expected to account for the largest share of the POC and rapid diagnostic market in 2018. This can be attributed to the increasing prevalence of diabetes mellitus across the globe. On the basis of application, the POC and rapid diagnostic market is segmented into hospital laboratories, digital diagnostics centers/clinics/hospitals/laboratories, homecare settings, and other applications such as veterinary clinics & hospitals etc.
Product Definition:
Point of Care and Rapid Diagnostic is a term used to describe the use of technology and tools that allow for the diagnosis of a condition or disease at the time it is being treated. The importance of Point of Care and Rapid Diagnostic is that it allows for faster treatment decisions, which can lead to improved patient outcomes.
SBMG:
SBMG (Small Blood Vessels Microscopy) is a non-invasive medical procedure that utilizes light to examine small blood vessels in the skin. It helps detect and diagnose diseases such as skin cancer, lesions, warts, vascular abnormalities & other infections. SBMG has applications in various fields such as dermatology/skin care management, internal medicine (infectious & otherwise), pathology and others.
Infectious Disease:
Infectious diseases are those that are caused by pathogens (agents causing disease) and can be transmitted from one individual to another. The most common infectious diseases include the ones against which preventive measures are taken such as immunization, antibiotics for treatment, and prophylaxis (prevention) through various methods.
Application Insights:
Based on application, the global point of care and rapid diagnostic market is segmented into hospital, homecare, and digital diagnostics. The hospital segment dominated the overall market in terms of revenue in 2017 due to factors such as increasing prevalence of chronic diseases that require immediate medical attention. Furthermore, an increase in healthcare spending by governments as well as private organizations has resulted in growth for this segment.
The homecare application is expected to witness a lucrative CAGR over the forecast period owing to factors such as rising geriatric population across the globe who are more susceptible to infections which may go undetected for longer periods resulting in delayed treatment or improper diagnosis at a later stage which can be life-threatening. In addition, an increase in incidence of trauma cases where prompt diagnosis at primary site saves lives by enabling effective treatment is anticipated to boost product demand over forecast period.
Digital diagnostics have been gaining traction rapidly owing to their convenience.
Regional Analysis:
North America dominated the global market in 2017. The presence of well-established healthcare infrastructure, high adoption rate of advanced technologies, and increasing demand for rapid diagnostic solutions are some major factors responsible for its large share. Moreover, the region is anticipated to maintain its dominance during the forecast period due to continuous innovations and technological advancements in medical devices & diagnostics.
Asia Pacific is expected to grow at a lucrative CAGR over the forecast period owing to unmet needs regardingto healthcare facilities in various countries such as China & India along with other Southeast Asian nations that compel people towards homecare diagnosis resulting into huge revenue generation opportunities for players operating within this regional space. Furthermore, rising disposable income levels coupled with growing awareness about early disease detection will also boost growth prospects within Asia Pacific region over next eight years (2030).
Growth Factors:
- Increasing demand for point of care and rapid diagnostic tests due to rising incidence of lifestyle diseases such as diabetes and heart disease.
- Growing awareness about the benefits of early diagnosis and treatment among patients, healthcare professionals, and policy makers.
- Technological advances that have led to the development of novel point-of-care tests with improved accuracy and speed.
- Rising demand for personalized medicine that can provide targeted treatment based on an individual's genetic profile or biomarkers.
- Increased funding for research on new point-of-care diagnostics technologies from public and private sector organizations
Scope Of The Report
Report Attributes
Report Details
Report Title
Point of Care and Rapid Diagnostic Market Research Report
By Type
SBMG, Infectious Disease, Coagulation
By Application
Hospital, Digital Diagnostic, Homecare
By Companies
Roche Diagnostics, Siemens Healthineers, Danaher Corporation, Becton Dickinson and Company, Abbott Laboratories, Quidel Diagnostics, Chembio Diagnostics, EKF Diagnostics, Trinity Biotech, Fluxergy
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
128
Number of Tables & Figures
90
Customization Available
Yes, the report can be customized as per your need.
Global Point of Care and Rapid Diagnostic Market Report Segments:
The global Point of Care and Rapid Diagnostic market is segmented on the basis of:
Types
SBMG, Infectious Disease, Coagulation
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Digital Diagnostic, Homecare
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche Diagnostics
- Siemens Healthineers
- Danaher Corporation
- Becton Dickinson and Company
- Abbott Laboratories
- Quidel Diagnostics
- Chembio Diagnostics
- EKF Diagnostics
- Trinity Biotech
- Fluxergy
Highlights of The Point of Care and Rapid Diagnostic Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- SBMG
- Infectious Disease
- Coagulation
- By Application:
- Hospital
- Digital Diagnostic
- Homecare
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Point of Care and Rapid Diagnostic Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Point of care (POC) and rapid diagnostic are terms used to describe the process of providing a diagnosis or prognosis from a doctor or other health professional who is close to the patient. Point of care refers specifically to situations in which clinicians are available immediately, while rapid diagnostic refers more broadly to any form of diagnostics that can be performed quickly and without requiring extensive laboratory testing.
Some of the major companies in the point of care and rapid diagnostic market are Roche Diagnostics, Siemens Healthineers, Danaher Corporation, Becton Dickinson and Company, Abbott Laboratories, Quidel Diagnostics, Chembio Diagnostics, EKF Diagnostics, Trinity Biotech, Fluxergy.
The point of care and rapid diagnostic market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Point of Care and Rapid Diagnostic Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Point of Care and Rapid Diagnostic Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Point of Care and Rapid Diagnostic Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Point of Care and Rapid Diagnostic Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Point of Care and Rapid Diagnostic Market Size & Forecast, 2018-2028
4.5.1 Point of Care and Rapid Diagnostic Market Size and Y-o-Y Growth
4.5.2 Point of Care and Rapid Diagnostic Market Absolute $ Opportunity
Chapter 5 Global Point of Care and Rapid Diagnostic Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Point of Care and Rapid Diagnostic Market Size Forecast by Type
5.2.1 SBMG
5.2.2 Infectious Disease
5.2.3 Coagulation
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Point of Care and Rapid Diagnostic Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Point of Care and Rapid Diagnostic Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Digital Diagnostic
6.2.3 Homecare
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Point of Care and Rapid Diagnostic Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Point of Care and Rapid Diagnostic Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Point of Care and Rapid Diagnostic Analysis and Forecast
9.1 Introduction
9.2 North America Point of Care and Rapid Diagnostic Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Point of Care and Rapid Diagnostic Market Size Forecast by Type
9.6.1 SBMG
9.6.2 Infectious Disease
9.6.3 Coagulation
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Point of Care and Rapid Diagnostic Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Digital Diagnostic
9.10.3 Homecare
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Point of Care and Rapid Diagnostic Analysis and Forecast
10.1 Introduction
10.2 Europe Point of Care and Rapid Diagnostic Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Point of Care and Rapid Diagnostic Market Size Forecast by Type
10.6.1 SBMG
10.6.2 Infectious Disease
10.6.3 Coagulation
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Point of Care and Rapid Diagnostic Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Digital Diagnostic
10.10.3 Homecare
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Point of Care and Rapid Diagnostic Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Point of Care and Rapid Diagnostic Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Point of Care and Rapid Diagnostic Market Size Forecast by Type
11.6.1 SBMG
11.6.2 Infectious Disease
11.6.3 Coagulation
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Point of Care and Rapid Diagnostic Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Digital Diagnostic
11.10.3 Homecare
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Point of Care and Rapid Diagnostic Analysis and Forecast
12.1 Introduction
12.2 Latin America Point of Care and Rapid Diagnostic Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Point of Care and Rapid Diagnostic Market Size Forecast by Type
12.6.1 SBMG
12.6.2 Infectious Disease
12.6.3 Coagulation
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Point of Care and Rapid Diagnostic Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Digital Diagnostic
12.10.3 Homecare
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Point of Care and Rapid Diagnostic Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Point of Care and Rapid Diagnostic Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Point of Care and Rapid Diagnostic Market Size Forecast by Type
13.6.1 SBMG
13.6.2 Infectious Disease
13.6.3 Coagulation
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Point of Care and Rapid Diagnostic Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Digital Diagnostic
13.10.3 Homecare
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Point of Care and Rapid Diagnostic Market: Competitive Dashboard
14.2 Global Point of Care and Rapid Diagnostic Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche Diagnostics
14.3.2 Siemens Healthineers
14.3.3 Danaher Corporation
14.3.4 Becton Dickinson and Company
14.3.5 Abbott Laboratories
14.3.6 Quidel Diagnostics
14.3.7 Chembio Diagnostics
14.3.8 EKF Diagnostics
14.3.9 Trinity Biotech
14.3.10 Fluxergy
